In pancreatic cancer, PEDF was found to serve as an anti-inflammatory immunomodulator that inhibits macrophage activation and migration45, whereas in prostate cancer it was found to induce migration of M1-type differentiated macrophages46,47. Here, SERPINF1 is linked to Familial prostate cancer.